NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS)
NASDAQ · Healthcare
$29.67-6.34%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $3.89B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,629,849
- 52-week high
- —
- 52-week low
- —
- Open
- $31.73
- Day high
- $32.19
- Day low
- $29.57
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $22.5M | -$203.82M | -$1.72 |
| 2024 | $45.56M | -$241.6M | -$2.56 |
| 2023 | $14.09M | -$176.94M | -$2.15 |
| 2022 | $102.69M | -$22.63M | -$1.19 |
| 2021 | — | -$41.79M | -$3.81 |
About NewAmsterdam Pharma Company N.V. - Ordinary Shares
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer’s disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
- CEO
- Michael Davidson
- Employees
- 100
- Country
- NL
- IPO date
- Feb 9, 2021
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is NewAmsterdam Pharma Company N.V. - Ordinary Shares's stock price today?
- NAMS is trading at $29.67 as of Jul 20, 2026.
- What is NewAmsterdam Pharma Company N.V. - Ordinary Shares's market cap?
- NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS) has a market capitalization of $3.89B.
- Does NewAmsterdam Pharma Company N.V. - Ordinary Shares pay a dividend?
- NewAmsterdam Pharma Company N.V. - Ordinary Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is NewAmsterdam Pharma Company N.V. - Ordinary Shares in?
- NewAmsterdam Pharma Company N.V. - Ordinary Shares operates in the Healthcare sector.